Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
BOB (psychedelic)
Подписчиков: 0, рейтинг: 0
Names | |
---|---|
Preferred IUPAC name
2-(4-Bromo-2,5-dimethoxyphenyl)-2-methoxyethan-1-amine | |
Other names
4-Bromo-2,5,β-trimethoxyphenethylamine
2-(4-Bromo-2,5,β-trimethoxyphenyl)ethanamine | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C11H16BrNO3 | |
Molar mass | 290.157 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
BOB (4-bromo-2,5,beta-trimethoxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-methoxy analog of 2C-B. BOB was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 10–20 mg, and the duration listed as 10–20 hours. BOB produces an altered state of consciousness, tinnitus, a pleasant tingling throughout the body, and a sense of awareness. Very little data exists about the pharmacological properties, metabolism, and toxicity of BOB.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.